News

The Latvian Medicines Verification System (LZVS) has successfully passed all compatibility tests so that the Latvian national system is prepared for European Medicines Verification System (EU Hub) updates / system release 1.9. LZVS is ready to work without interruption and restriction

In the first quarter of 2021, in the medicines verification system, which guarantees the safety and authenticity of prescription medicines, 5.8 million packages of medicines were verified and have reached consumers.

On 13 January 2021, the European Commission adopted a new Delegated Regulation, amending Delegated Regulation (EU) 2016/161 as regards a derogation from the obligation of wholesalers to decommission the unique identifier of products exported to the United Kingdom.

The Latvian medicines verification system, which was established in Latvia to check the safety of medicines and prevent people from receiving or buying falsified medicines, has been fully operational for almost two years.

European Medicines Verification Organisation (EMVO) was published frequently asked questions regarding verification system and Brexit.

Attesting their qualification and high operating standards of the LZVO, more and more specialists of the Latvian Medicines Verification Organisation (LZVO) hold positions at the international level.